Richardson, P. G., Soiffer, R. J., Antin, J. H., Jin, Z., Kurtzberg, J., Martin, P. L., … Guinan, E. C. (2005). Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV. In BLOOD (Vol. 106, pp. 120A-120A). Atlanta, GA: AMER SOC HEMATOLOGY.

Richardson, P. G., R. J. Soiffer, J. H. Antin, Z. Jin, J. Kurtzberg, P. L. Martin, D. Hockenbery, et al. “Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.” In BLOOD, 106:120A-120A. AMER SOC HEMATOLOGY, 2005.

Richardson PG, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, et al. Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV. In: BLOOD. AMER SOC HEMATOLOGY; 2005. p. 120A-120A.

Richardson, P. G., et al. “Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.” BLOOD, vol. 106, no. 11, AMER SOC HEMATOLOGY, 2005, pp. 120A-120A.

Richardson PG, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, Hockenbery D, Murray KF, Vogelsang GB, Chen A, Krishnan A, Kernan NA, Avigan D, Spitzer TR, Warren D, Momtaz P, Revta C, Wei LJ, Iacobelli M, McDonald GB, Guinan EC. Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV. BLOOD. AMER SOC HEMATOLOGY; 2005. p. 120A-120A.